In mice models, bioorthogonal system to gasdermin (a technique that is able to control the release of active gasdermin in mice and selectively enter mouse tumor cells) could increase CD4+ and CD8+ cells in the TME of BC, while the percentage of CD4+ Foxp3+ regulatory T cells decreased, which showed a strong antitumor effect. This evidence concerns the gene CD4 and breast cancer.